Inovio Pharmaceuticals In... (INO)

NASDAQ: INO · Real-Time Price · USD

1.91

0.02 (1.06%)

At close: May 02, 2025, 3:59 PM

1.95

2.09%

After-hours: May 02, 2025, 05:04 PM EDT

Inovio Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	217.76K	832.01K	10.26M	1.77M	7.41M	4.11M	30.48M	42.22M	35.37M
Cost of Revenue	3.13M	3.5M	5.5M	4.73M	94.25M	88.02M	n/a	n/a	n/a
Gross Profit	-2.91M	-2.67M	4.77M	-2.96M	-86.83M	-83.91M	30.48M	42.22M	35.37M
Operating Income	-112.4M	-143.94M	-267.57M	-301.22M	-124.08M	-111.11M	-94.09M	-83.64M	-76.24M
Interest Income	4.77M	8.13M	4.78M	3.36M	3.31M	2.61M	2.26M	1.61M	1.4M
Pretax Income	-107.25B	-135.12M	-277.65M	-303.22M	-162.89M	-120.81M	-94.8M	-88.21M	-73.74M
Net Income	-107.25M	-135.12M	-287.66M	-305.38M	-215.09M	-120.55M	-96.97M	-88.21M	-73.74M
Selling & General & Admin	37M	47.58M	90.19M	53.75M	37.25M	27.2M	29.32M	28.29M	23.89M
Research & Development	75.62M	86.68M	187.65M	249.24M	94.25M	88.02M	95.26M	98.57M	88.71M
Other Expenses	n/a	10.51M	-3.86M	343.37K	3.42M	496.2K	360.8K	806.82K	127.55K
Operating Expenses	111.09M	144.77M	277.84M	302.99M	131.49M	115.22M	124.57M	126.86M	112.6M
Interest Expense	177.83K	1.22M	1.25M	1.94M	8.7M	7.95M	346.09K	4.56M	139.25K
Selling & Marketing Expenses	-36.96B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	112.62M	144.77M	277.84M	302.99M	131.49M	115.22M	124.57M	126.86M	112.6M
Income Tax Expense	-107.15B	n/a	10.01M	2.16M	52.2M	-257.33K	2.17M	1.76M	-4.62M
Shares Outstanding (Basic)	27.16M	22.17M	19.89M	17.4M	12.93M	8.23M	92.35M	81.78M	73.01M
Shares Outstanding (Diluted)	27.16M	22.17M	19.89M	17.4M	12.93M	8.23M	92.54M	81.92M	73.21M
EPS (Basic)	-3.95	-6.09	-14.47	-17.55	-16.64	-14.65	-1.05	-1.08	-1.01
EPS (Diluted)	-3.95	-6.09	-14.47	-17.55	-16.64	-14.65	-1.05	-1.08	-1.01
EBITDA	-103.95M	-130.39M	-270.9M	-296.56M	-149.56M	-107.34M	-89.8M	-84.74M	-74.15M
EBIT	-107.08M	-133.89M	-276.4M	-301.29M	-154.19M	-112.86M	-94.8M	-88.18M	-77.24M
Depreciation & Amortization	3.13M	3.5M	5.5M	4.73M	4.63M	5.52M	5M	3.47M	3.09M